Iberri, David J <br/><br/>
Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck.  [electronic resource] 

 -  The oncologist  Dec 2015 
 - 1393-403 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1549-490X 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.2015-0177  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cetuximab--administration & dosage<br/>Chemotherapy, Adjuvant<br/>ErbB Receptors--antagonists & inhibitors<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Molecular Targeted Therapy--methods<br/>Protein Kinase Inhibitors--adverse effects<br/>Squamous Cell Carcinoma of Head and Neck